NASDAQ:NAOV NanoVibronix (NAOV) Stock Price, News & Analysis $3.07 -0.36 (-10.50%) Closing price 04:00 PM EasternExtended Trading$3.11 +0.04 (+1.30%) As of 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends About NanoVibronix Stock (NASDAQ:NAOV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NanoVibronix alerts:Sign Up Key Stats Today's Range$3.03▼$3.4350-Day Range$0.24▼$3.4352-Week Range$1.92▼$13.97Volume710,229 shsAverage Volume261,855 shsMarket Capitalization$2.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.Read More… Remove Ads NanoVibronix Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScoreNAOV MarketRank™: NanoVibronix scored higher than 3% of companies evaluated by MarketBeat, and ranked 932nd out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for NanoVibronix. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of NanoVibronix is -2.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NanoVibronix is -2.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNanoVibronix has a P/B Ratio of 1.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about NanoVibronix's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.08% of the float of NanoVibronix has been sold short.Short Interest Ratio / Days to CoverNanoVibronix has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NanoVibronix has recently increased by 179.62%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNanoVibronix does not currently pay a dividend.Dividend GrowthNanoVibronix does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.08% of the float of NanoVibronix has been sold short.Short Interest Ratio / Days to CoverNanoVibronix has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NanoVibronix has recently increased by 179.62%, indicating that investor sentiment is decreasing significantly. News and Social Media1.7 / 5News Sentiment-0.02 News SentimentNanoVibronix has a news sentiment score of -0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for NanoVibronix this week, compared to 0 articles on an average week.Search Interest3 people have searched for NAOV on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, NanoVibronix insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.00% of the stock of NanoVibronix is held by insiders.Percentage Held by InstitutionsOnly 16.39% of the stock of NanoVibronix is held by institutions.Read more about NanoVibronix's insider trading history. Receive NAOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter. Email Address NAOV Stock News HeadlinesNanoVibronix Stock Short Interest Report | NASDAQ:NAOV | BenzingaMarch 18 at 9:36 AM | benzinga.comNanoVibronix Stock Price, Quotes and Forecasts | NASDAQ:NAOV | BenzingaMarch 18 at 9:36 AM | benzinga.comIs 2025 really the best time to get rich in American history?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.March 18, 2025 | Paradigm Press (Ad)NanoVibronix announces UroShield health service study data publishedMarch 14, 2025 | markets.businessinsider.comNanoVibronix’s UroShield Study Published in Medical JournalMarch 14, 2025 | tipranks.comSuccessful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence JournalMarch 14, 2025 | businesswire.comNanoVibronix Inc trading halted, news pendingMarch 13, 2025 | markets.businessinsider.comNanoVibronix announces 1 for 11 reverse stock splitMarch 12, 2025 | markets.businessinsider.comSee More Headlines NAOV Stock Analysis - Frequently Asked Questions How have NAOV shares performed this year? NanoVibronix's stock was trading at $0.59 on January 1st, 2025. Since then, NAOV shares have increased by 450.7% and is now trading at $3.2490. View the best growth stocks for 2025 here. How were NanoVibronix's earnings last quarter? NanoVibronix, Inc. (NASDAQ:NAOV) posted its quarterly earnings data on Wednesday, November, 14th. The company reported ($0.11) earnings per share (EPS) for the quarter. The business had revenue of $0.05 million for the quarter. NanoVibronix had a negative trailing twelve-month return on equity of 101.17% and a negative net margin of 93.80%. When did NanoVibronix's stock split? Shares of NanoVibronix reverse split on Friday, March 14th 2025. The 1-11 reverse split was announced on Wednesday, March 12th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, March 13th 2025. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split. How do I buy shares of NanoVibronix? Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NanoVibronix own? Based on aggregate information from My MarketBeat watchlists, some other companies that NanoVibronix investors own include Exela Technologies (XELA), Assertio (ASRT), Meta Platforms (META), T2 Biosystems (TTOO), NIO (NIO), Senseonics (SENS) and SNDL (SNDL). Company Calendar Last Earnings11/14/2018Today3/18/2025Next Earnings (Estimated)4/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:NAOV CIK1326706 Webwww.nanovibronix.com Phone(914) 233-3004Fax914-376-6111Employees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($13.53) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,710,000.00 Net Margins-93.80% Pretax Margin-93.04% Return on Equity-101.17% Return on Assets-53.03% Debt Debt-to-Equity RatioN/A Current Ratio1.74 Quick Ratio0.84 Sales & Book Value Annual Sales$3.29 million Price / Sales0.78 Cash FlowN/A Price / Cash FlowN/A Book Value$1.95 per share Price / Book1.67Miscellaneous Outstanding Shares792,000Free Float3,489,000Market Cap$2.57 million OptionableNot Optionable Beta1.81 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:NAOV) was last updated on 3/18/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredIs this the End of the AI Boom?If you’re worried about all the recent volatility in the market… Or if you have any money in AI stocks… ...Brownstone Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredTitanic SyndromeStocks are experiencing a pattern known as the "Titanic Syndrome." I'm talking about the dramatic jump in t...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoVibronix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.